Skip to main content

PNC-27

No sources yet

An index of captured practitioner sources, not a completed evidence summary. Unchecked figures and empty sections are omitted. See the library review status.

Source summary generated November 6, 2026; this date does not indicate completed review.

Not yet categorized
Track your own protocol free →

Quotes from three independent practitioners, with their sources. Research context only.

What it is and how it works

From the published literature on PNC-27; the papers are listed at the end. Research summary, not a recommendation.

What it is

PNC-27 is a synthetic research peptide built from two parts: residues 12 to 26 of the human tumour-suppressor protein p53 (the stretch that binds the protein HDM-2) joined to penetratin, a short membrane-crossing sequence. PNC-28 is a shorter version using residues 17 to 26. Almost all published work comes from one research group at SUNY Downstate in New York, and all of it is in cultured cells, patient tumour cells grown in the lab, and mice.

How it works

HDM-2 (also called MDM2) is a protein that normally sits inside cells and tags p53 for destruction. The research group reported that many cancer cells, but few normal cells, carry HDM-2 on their outer membrane. In their lab work PNC-27 bound to this membrane HDM-2, the bound pairs joined up to form pores through the membrane, and the cell contents leaked out, killing the cell by necrosis (bursting) rather than by programmed cell death. Normal cells with little membrane HDM-2 were reported to be unaffected. These mechanism claims have not been independently confirmed by other laboratories.

What it has been studied for

  • Killing of cancer cell lines with membrane HDM-2 (lab studies)
  • Leukaemia cells versus normal blood-forming cells (lab studies)
  • Patient-derived ovarian cancer cells (lab studies)
  • Pancreatic tumour growth in mice (PNC-28, animal study)
  • Pore formation in cancer-cell membranes (lab studies and reviews)

Strength of the evidence

Animal and lab studiesThe published evidence is cell-culture work and mouse tumour studies, nearly all from a single group; no human study has been published.

What the literature reports on safety

The group reported no harm to normal cells in culture and no obvious off-target effects in mice, but no human safety data exist. PNC-27 is not approved by the FDA or any regulator and has not entered a registered clinical trial. One author of the main review declared employment by a company developing the peptide, and the findings have not been reproduced by an independent group.

Key papers

  1. Poptosis or Peptide-Induced Transmembrane Pore Formation: A Novel Way to Kill Cancer Cells without Affecting Normal Cells (opens in a new tab)

    Review · Pincus MR, Silberstein M, et al. · Biomedicines (2024) · PMID 38927351

    The developing group reviewed its work and described PNC-27 and PNC-28 binding membrane HDM-2 and forming pores that burst cancer cells, with tumour control in mice and no effect on normal cells.

  2. Anti-cancer peptides from ras-p21 and p53 proteins (opens in a new tab)

    Review · Pincus MR, Fenelus M, et al. · Current Pharmaceutical Design (2011) · PMID 21728981

    An earlier review from the same group of the anticancer peptides it designed from the p53 and ras-p21 proteins, including PNC-27 and PNC-28.

  3. Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes (opens in a new tab)

    Lab (in vitro) · Sarafraz-Yazdi E, Bowne WB, et al. · Proceedings of the National Academy of Sciences of the USA (2010) · PMID 20080680

    Found HDM-2 in the membranes of several cancer cell lines but not normal lines, and normal cells became susceptible to PNC-27 once engineered to carry membrane HDM-2.

  4. PNC-27, a Chimeric p53-Penetratin Peptide Binds to HDM-2 in a p53 Peptide-like Structure, Induces Selective Membrane-Pore Formation and Leads to Cancer Cell Lysis (opens in a new tab)

    Lab (in vitro) · Sarafraz-Yazdi E, Mumin S, et al. · Biomedicines (2022) · PMID 35625682

    Reported that PNC-27 bound membrane HDM-2 and formed pores selectively in cancer-cell membranes, leading to cell lysis.

  5. Targeting Membrane HDM-2 by PNC-27 Induces Necrosis in Leukemia Cells But Not in Normal Hematopoietic Cells (opens in a new tab)

    Lab (in vitro) · Thadi A, Lewis L, et al. · Anticancer Research (2020) · PMID 32878773

    In culture, PNC-27 caused necrosis of leukaemia cells but not of normal blood-forming cells.

Sources checked: PubMed/PMC (E-utilities esummary and abstracts on every PMID), ClinicalTrials.gov (no registered trial found), written 2026-11-06.

No sources yet

None of the three teachers' sources we have indexed discuss PNC-27 yet. This page will fill in as sources are added.

Deeper guided audio lives on What Am I Appreciating Now (leaves this site, opens in a new tab). What Am I Appreciating Now is a separate site run by the same operator; it sells meditation and hypnosis sessions.

Disclaimer: for research purposes only

All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol.If your path includes peptides, you buy them yourself from an independent licensed provider through a member co-op; we take nothing. How independent access works.

PNC-27 — Hunter, Taylor, Bachmeyer | Reset Biology